Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.21.1
Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2021
Dec. 31, 2020
Current Assets    
Cash $ 592,940 $ 950,537
Prepaid expenses 120,445 113,562
Total Current Assets 713,385 1,064,099
Security deposit 329 329
Marketable securities held in trust account 350,279,969 350,219,336
TOTAL ASSETS 350,993,683 351,283,764
Current liabilities    
Accounts payable and accrued expenses 335,278 239,531
Income taxes payable 13,742 11,509
Total Current Liabilities 349,020 251,040
Derivative warrant liability 29,888,618 66,126,490
Deferred underwriting fee payable 13,150,000 13,150,000
Total Liabilities 43,387,638 79,527,530
Commitments and Contingencies
Class A common stock subject to possible redemption, 30,260,604 and 26,675,623 shares at $10.00 per share as of March 31, 2021 and December 31, 2020, respectively 302,606,040 266,756,230
Stockholders’ Equity    
Preferred Stock, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding
Class A common stock, $0.0001 par value; 380,000,000 shares authorized; 4,739,396 and 8,324,377 shares issued and outstanding (excluding 30,260,604 and 26,675,623 shares subject to possible redemption) as of March 31, 2021 and December 31, 2020, respectively 474 832
Class B common stock, $0.0001 par value; 20,000,000 shares authorized; 8,750,000 shares issued and outstanding as of March 31, 2021 and December 31, 2020 875 875
Additional paid-in capital 8,418,024 44,267,467
Accumulated deficit (3,419,368) (39,269,179)
Total Stockholders’ Equity 5,000,005 5,000,004
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $ 350,993,683 $ 351,283,764